A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

NCT06169995 PHASE4 COMPLETED

The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for sedation in Upper Gastrointestinal Endoscopy

Details

Lead sponsor	Jiangsu HengRui Medicine Co., Ltd.
Phase	PHASE4
Status	COMPLETED
Enrolment	31
Start date	Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Dec 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sedation in the Upper Gastrointestinal Endoscopy

Interventions

• Remimazolam Tosilate

Countries

China